Tags

Type your tag names separated by a space and hit enter

The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Postgrad Med. 2004 Oct; 116(4):49-51, 55-9, 63.PM

Abstract

Five new antipsychotic drugs introduced in the United States in the last decade offer physicians the ability to treat patients with schizophrenia and bipolar mania without the adverse effects of the first-generation antipsychotics. In this article, the authors discuss the advantages and side effects of these agents and present a guide to help physicians choose the optimal drug in the most favorable formulation for each patient.

Authors+Show Affiliations

Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA. citrome@nki.rfmh.orgNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

15510593

Citation

Citrome, Leslie, and Jan Volavka. "The Promise of Atypical Antipsychotics: Fewer Side Effects Mean Enhanced Compliance and Improved Functioning." Postgraduate Medicine, vol. 116, no. 4, 2004, pp. 49-51, 55-9, 63.
Citrome L, Volavka J. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. Postgrad Med. 2004;116(4):49-51, 55-9, 63.
Citrome, L., & Volavka, J. (2004). The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. Postgraduate Medicine, 116(4), 49-51, 55-9, 63.
Citrome L, Volavka J. The Promise of Atypical Antipsychotics: Fewer Side Effects Mean Enhanced Compliance and Improved Functioning. Postgrad Med. 2004;116(4):49-51, 55-9, 63. PubMed PMID: 15510593.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. AU - Citrome,Leslie, AU - Volavka,Jan, PY - 2004/10/30/pubmed PY - 2004/12/16/medline PY - 2004/10/30/entrez SP - 49-51, 55-9, 63 JF - Postgraduate medicine JO - Postgrad Med VL - 116 IS - 4 N2 - Five new antipsychotic drugs introduced in the United States in the last decade offer physicians the ability to treat patients with schizophrenia and bipolar mania without the adverse effects of the first-generation antipsychotics. In this article, the authors discuss the advantages and side effects of these agents and present a guide to help physicians choose the optimal drug in the most favorable formulation for each patient. SN - 0032-5481 UR - https://www.unboundmedicine.com/medline/citation/15510593/The_promise_of_atypical_antipsychotics:_fewer_side_effects_mean_enhanced_compliance_and_improved_functioning_ L2 - https://www.tandfonline.com/doi/full/10.3810/pgm.2004.10.1601 DB - PRIME DP - Unbound Medicine ER -